Skip to main content
Clinical Trials/NCT02928302
NCT02928302
Withdrawn
Phase 3

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth

Federico II University1 site in 1 countryJuly 23, 2018
ConditionsPreterm Birth

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Federico II University
Locations
1
Primary Endpoint
preterm birth rate
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.

However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, we aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy without prior spontaneous PTB

Registry
clinicaltrials.gov
Start Date
July 23, 2018
End Date
December 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Federico II University
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

MD

Federico II University

Eligibility Criteria

Inclusion Criteria

  • 18-50 years of age
  • Singleton pregnancy (limits the participants to female gender)
  • No prior spontaneous preterm delivery, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks

Exclusion Criteria

  • Multiple gestation
  • Prior spontaneous preterm birth 16-36 6/7 weeks
  • Ruptured membranes at time of randomization
  • Lethal fetal structural anomaly at time of randomization
  • Fetal chromosomal abnormality at time of randomization
  • Placenta previa and/or accreta at time of randomization
  • Women who already underwent TVU CL measurement during the index pregnancy

Outcomes

Primary Outcomes

preterm birth rate

Time Frame: Less than 37 weeks

either spontaneous or indicated preterm delivery

Secondary Outcomes

  • Neonatal death(Between birth and 28 days of age)
  • intraventricular hemorrhage (grade 3 or higher)(Between birth and 28 days of age)
  • necrotizing enterocolitis(Between birth and 28 days of age)
  • Perinatal death(Between birth and 28 days of age)
  • gestational age at delivery(time of delivery)
  • latency(time of delivery)
  • admission to neonatal intensive care unit(time of delivery)
  • preterm birth rates(Less than 24, 28, 32, 30, and 34 weeks gestation)
  • Composite perinatal outcome(Between birth and 28 days of age)
  • Length of hospital stay(Discharge from hospital)
  • respiratory distress syndrome(Time of delivery)
  • birth weight(time of delivery)

Study Sites (1)

Loading locations...

Similar Trials